Orbitech Co., Ltd. (KOSDAQ:046120)

South Korea flag South Korea · Delayed Price · Currency is KRW
3,845.00
-5.00 (-0.13%)
At close: Aug 13, 2025, 3:30 PM KST
-0.13%
Market Cap103.60B
Revenue (ttm)63.23B
Net Income (ttm)8.51B
Shares Out27.12M
EPS (ttm)313.50
PE Ratio12.19
Forward PEn/a
Dividendn/a
Ex-Dividend Daten/a
Volume214,216
Average Volume634,483
Open3,915.00
Previous Close3,850.00
Day's Range3,820.00 - 3,925.00
52-Week Range1,791.00 - 6,570.00
Beta1.18
RSI45.89
Earnings DateAug 11, 2025

About Revance Therapeutics

Orbitech Co., Ltd. engages in the nuclear energy, ISI, and aviation businesses in South Korea and internationally. The company provides radiation management of nuclear power plants and nuclear-related facilities, non-destructive testing, deregulation of radioactive waste, and radiation measurement and related products; operation of nuclear power plants, and non-destructive technology inspection, etc. It also manufactures and assembles parts for aircraft, including tail fuselage structure bulkhead assembly and precision machining parts, as well ... [Read more]

Industry Business Services, not elsewhere classified
Founded 1991
Employees 428
Stock Exchange KOSDAQ
Ticker Symbol 046120
Full Company Profile

Financial Performance

Financial Statements

News

There is no news available yet.